Cancer Research UK logo.
SearchDonate
  • Search

A study looking at ribociclib and letrozole for people with advanced breast cancer (COMPLEEMENT-1)

Overview

Cancer types:

Breast cancer

Status:

Closed

Phase:

Phase 3

Details

This study is for people with breast cancer that has come back in the area where it was first found, or that has spread elsewhere in the body.

It is open to men and women whose breast cancer cells have:

  • receptors for oestrogen or progesterone (hormone receptor positive)

  • low or no amounts of HER2 (HER2 negative breast cancer)

Also, they have not had any hormone therapy for their advanced breast cancer.

Recruitment start: 1 March 2017

Recruitment end: 30 November 2017

How to join

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Dr Alistair Ring

Supported by

Novartis

Last reviewed: 2 March 2018

CRUK internal database number: 14412

The Dangoor Education logo.

Dangoor Education

About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education

Patient Information Forum. Trusted Information Creator.
Plain English Campaign award.

Help and support

An icon of a hand shake.

Questions for your doctor

What to ask your doctor about clinical trials.

An icon of two speech bubbles, indicating a conversation.

Cancer chat forum

Meet and chat to other cancer people affected by cancer.

An icon of a landline phone.

Nurse helpline

Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.